Although a lot of clinical studies have demonstrated that individuals with hypertension are more susceptible to COVID-19 and have a worse prognosis, however little emphasis has been paid to the role that NF-κB activation plays in its causes, development, diagnosis, and therapeutics. This evidence concerns the gene NFKB1 and hypertensive disorder.